Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Nanoparticle-based systems for concurrent delivery of multiple drugs can improve outcomes of cancer treatments, but face challenges because of differential solubility and fairly low threshold for incorporation of many drugs. Here we demonstrate that this approach can be used to greatly improve the treatment outcomes of etoposide (ETO) and platinum drug combination ("EP/PE") therapy that is the backbone for treatment of prevalent and deadly small cell lung cancer (SCLC). A polymeric micelle system based on amphiphilic block copolymer poly(2-oxazoline)s (POx) poly(2-methyl-2-oxazoline- block-2-butyl-2-oxazoline- block-2-methyl-2-oxazoline) (P(MeOx- b-BuOx- b-MeOx) is used along with an alkylated cisplatin prodrug to enable co-formulation of EP/PE in a single high-capacity vehicle. A broad range of drug mixing ratios and exceptionally high two-drug loading of over 50% wt. drug in dispersed phase is demonstrated. The highly loaded POx micelles have worm-like morphology, unprecedented for drug loaded polymeric micelles reported so far, which usually form spheres upon drug loading. The drugs co-loading in the micelles result in a slowed-down release, improved pharmacokinetics, and increased tumor distribution of both drugs. A superior antitumor activity of co-loaded EP/PE drug micelles compared to single drug micelles or their combination as well as free drug combination was demonstrated using several animal models of SCLC and non-small cell lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Triblock A-B-A copolymers of POx consisting of hydrophobic PBuOx block with two flanking hydrophilic PMeOx blocks, PMeOx-b-PBuOx-b-PMeOx, have shown unprecedentedly high loading for many poorly soluble drugs [22, 45, 113, 114].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the effective and safe delivery of drug combinations, the combination drugs should be well-solubilized in the polymeric micelle so that the amount of the excipient and injection volume can be minimized for parenteral injection [114, 188, 240].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A high LC also increases the amount of drug per micelle, which can increase the amount of drug internalized into cells [114].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They reported that the overall AUC of the drugs in the tumor from worm-like micelles were higher than from spherical micelles.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This study suggested that the worm-shaped POx micelles co-loaded with two drugs (etoposide and hydrophobic cisplatin analog) have increased accumulation of the drugs into tumor compared to spherical micelles loaded with just one drug.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [114]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S., & Johnson, D. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400403 · Cited by 1,506
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Arnida, Janát-Amsbury, M. M., Ray, A., Peterson, C. M., & Ghandehari, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.010 · Cited by 547
Miura, Y., Takenaka, T., Toh, K., Wu, S., Nishihara, H., Kano, M. R., Ino, Y., Nomoto, T., Matsumoto, Y., Koyama, H., et al. (2013) · ACS Nano · doi:10.1021/nn402662d · Cited by 454
Kalemkerian, G. P., Akerley, W., Bogner, P., Borghaei, H., Chow, L. Q., Downey, R. J., Gandhi, L., Ganti, A. K. P., Govindan, R., Grecula, J. C., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0011 · Cited by 436
Molecular mechanisms of etoposide.
Montecucco, A., Zanetta, F., & Biamonti, G. (2015) · EXCLI journal · doi:10.17179/excli2015-561 · Cited by 291
Research works printed but not linked: 3
- Chan B. A., 2013, J. Thorac. Dis., 5, S565
- Johnson S. W., 1997, Cancer Res., 57, 850
- Montecucco A., 2015, EXCLI Journal, 14, 95
Cited by
Items 101–161 of 161
Tolstik, E., Gongalsky, M. B., Dierks, J., Brand, T., Pernecker, M., Pervushin, N. V., Maksutova, D. E., Gonchar, K. A., Samsonova, J. V., Kopeina, G. S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.962763 · Cited by 13
Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment
Isaic, A., Davidescu, L., Motofelea, A. C., Ciocârlie, T., Motofelea, N., Costăchescu, D., Marc, M. S., Suppini, N., Şovrea, A. S., Coșeriu, R. L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011235 · Cited by 13
Xie, X., Yuan, Z., Yuan, Q., Huang, Y., Yu, Q., Ren, J., Liang, L., Jin, H., & Yu, J. (2020) · Colloid & Polymer Science · doi:10.1007/s00396-020-04778-2 · Cited by 13
Haider, M. S., Mahato, A. K., Котлярова, А. А., Forster, S., Böttcher, B., Stahlhut, P., Sidorova, Y. A., & Luxenhofer, R. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00761 · Cited by 14
Directing Amphiphilic Self-Assembly: From Microstructure Control to Interfacial Engineering
Hassan, P. A., & Gawali, S. L. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b02921 · Cited by 13
Li, S., Bobbala, S. K. R., Vincent, M. P., Modak, M., Liu, Y., & Scott, E. A. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100063 · Cited by 12
Mastering the complexities of cancer nanomedicine with text mining, AI and automation
Shamay, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.057 · Cited by 12
Structural and therapeutic properties of salicylic acid-solubilized Pluronic solutions and hydrogels
Ganguly, R., Kumar, S., Soumya, M., Khare, A., Bhainsa, K. C., Aswal, V. K., & Kohlbrecher, J. (2024) · Soft Matter · doi:10.1039/d4sm00079j · Cited by 11
Wang, J., Song, Y., Zhang, N., Li, N., Liu, C., & Wang, B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.658543 · Cited by 11
“Approximately 80–85% of lung cancers are non-small cell lung cancer (NSCLC), and 10−15% are small cell lung cancer (1).”
BackgroundChroni, A., Mavromoustakos, T., & Pispas, S. (2021) · Macromol—A Journal of Macromolecular Research · doi:10.3390/macromol1030014 · Cited by 13
“Numerous seminal research papers have reported the design of amphiphilic POx-based drug delivery systems, exploiting their hydrophobic core as a matrix for the confinement of curcumin (CUR) [4], indomethacin (IND) [30], paclitaxel (PTX) [31], doxorubicin (DOX) [32], dexamethasone (Dex) [33], cabazitaxel (CAB) [34], an…”
BackgroundPolyester, Polyhydroxyalkanoate Nanoparticles as a Promising Tool for Anticancer Therapeutics
Gorain, B., Choudhury, H., Pandey, M., Kokare, C., Khurana, R. K., Sehdev, A., & Kesharwani, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816963-6.00006-6 · Cited by 12
Poly(2-oxazoline)-based drug delivery systems for cancer therapy
Kulkarni, B., & Becer, C. R. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.114292 · Cited by 10
Chen, F., Xu, G., Tian, W., & Gou, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114785 · Cited by 11
Wang, Z., Zhou, J., Wang, J., Wang, M., Lyu, Q., Li, C., Sun, S., Faller, R., & Hu, S. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.09.057 · Cited by 10
Wu, D., Zeng, H., Tan, J., Xu, Q., Khan, F. A., Pandupuspitasari, N. S., Yang, S., & Huang, C. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s545163 · Cited by 10
Torchelsen, F. K. V. D. S., Lages, E. B., de Oliveira, M. A., de Barros, A. L. B., & Mosqueira, V. C. F. (2026) · Pharmaceuticals · doi:10.3390/ph19020248 · Cited by 9
Humphries, J., Warne, N. M., Feeney, O. M., Thurecht, K. J., & Kempe, K. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114838 · Cited by 11
Development of a Dual Drug-Loaded, Surfactant-Stabilized Contrast Agent Containing Oxygen
Patel, R. B., Lacerda, Q., Oeffinger, B. E., Eisenbrey, J. R., Rochani, A., Kaushal, G., Wessner, C. E., & Wheatley, M. A. (2022) · Polymers · doi:10.3390/polym14081568 · Cited by 9
Organic and inorganic nanoparticles
Rashid, E. U., Nawaz, S., Munawar, J., Sarker, A., Hussain, S., Iqbal, H. M. N., & Bilal, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91611-0.00014-1 · Cited by 10
Hu, L., He, C., Mo, A., Zhan, X., Yang, C., Guo, W. L., Sun, L., Su, W., & Lin, L. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/3436814 · Cited by 7
Miranda‐Vera, C., Hernández, Á., García, P. G., Diez, D., García, P. A., & Castro, M. A. (2025) · Pharmaceuticals · doi:10.3390/ph18020169 · Cited by 6
“Additionally, other drugs such as 5-fluorouracil [60], methotrexate [65] or cisplatin [70] have been introduced in the nanosystems, either forming hybrid compounds with podophyllotoxin or as part of final NPs, to improve podophyllotoxin nanoconjugates properties.”
Ultrasound-Driven Coassembly of Anticancer Drugs into Carrier-Free Particles
Mohankumar, M., Fernandes, S., Cavalieri, F., Cortez‐Jugo, C., & Caruso, F. (2025) · ACS Nano · doi:10.1021/acsnano.5c01284 · Cited by 6
Bardoliwala, D., Javia, A., Ghosh, S., Misra, A. R., & Sawant, K. K. (2021) · Therapeutic Delivery · doi:10.4155/tde-2020-0101 · Cited by 6
He, K., Zhang, Y.-F., Liang, L.-Y., Cheng, X., Gong, G., Ouyang, X.-M., Lin, Y., & Guleng, B. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.09.007 · Cited by 6
Crosstalk along the gut-liver axis modulates glutathione and cadmium-induced hepatotoxicity
Sivalingam, A. M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1758379 · Cited by 6
“This system demonstrates signi fi cantly improved antitumor ef fi cacy in both small cell and non-small cell lung cancer models (174).”
Searching for the synthetic methods towards siloxane molecular brushes
Obrezkova, M. A., Selifanova, A. A., Revenko, V. K., & Muzafarov, A. M. (2024) · Russian Chemical Bulletin · doi:10.1007/s11172-024-4138-5 · Cited by 5
The Trojan Horse Goes Wild: The Effect of Drug Loading on the Behavior of Nanoparticles
Stenzel, M. H. (2020) · Angewandte Chemie · doi:10.1002/ange.202010934 · Cited by 5
Кузнецова, Е. В., Sedush, N. G., Puchkova, Y. A., Aleshin, S. V., Yastremsky, E. V., Nazarov, A. A., & Чвалун, С. Н. (2023) · Polymers · doi:10.3390/polym15102296 · Cited by 5
“Thus, poly(2-methyl-2-oxazoline-b -2-butyl-2-oxazoline- b -2-methyl-2-oxazoline) (P(MeOx 37 - b -BuOx 21 - b -MeOx 36 )) NPs loaded with both etoposide and an alkylated cis-platin prodrug for deadly small cell lung cancer treatment were successfully obtained and studied in detail [33].”
BackgroundEtoposide-Loaded Colloidal Delivery Systems Based on Biodegradable Polymeric Carriers
Merkulova, M. A., Osipova, N., Kalistratova, A. V., Ermolenko, Y. V., & Gelperina, S. E. (2023) · Colloid Journal · doi:10.1134/s1061933x23600744 · Cited by 5
Nanomedicines: an update of diagnostic and therapeutic applications in multiple cancers
Shinde, S. J., Priyanka, Jakhar, M., Arora, I., Sehgal, D., Mahak, Kumari, A., Dhiman, T., Priya, Kumar, N., et al. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2613059 · Cited by 4
“Further improvement in safety using pH-sensitive lDH nano-hybrids, increasing uptake, promoting apoptosis via Pi3K–AKt and eRBB inhibition, tripling tumour suppression, and reducing hepatotoxicity and haematotoxicity [147,148].”
Hao, D., Zhang, Z., & Ji, Y. (2021) · International Journal of Polymeric Materials · doi:10.1080/00914037.2021.1960340 · Cited by 4
Setia, A., Mehata, A. K., Rengan, A. K., & Muthu, M. S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125872 · Cited by 3
Role of Copolymers in Lung Cancer
Verma, N., Kumar, J., Thapa, K., Kanojia, N., & Dua, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6917-3_8 · Cited by 3
Halupczok, S., Pfister, M., Ringhand, A., Fetsch, C., Cubukova, A., Appelt‐Menzel, A., & Luxenhofer, R. (2020) · Polymer Chemistry · doi:10.1039/d0py01258k · Cited by 4
Copolymers induced co-assembly for constructing novel micellar carriers by computer simulations
Du, K., Xia, Q., Zhang, L., Wen, J., Huang, Z., & Zhu, Z.-S. (2022) · Chemical Physics Letters · doi:10.1016/j.cplett.2022.139874 · Cited by 3
Engineered nanoparticle systems: A review on emerging strategies for enhanced cancer therapeutics
Sivasubramanian, P. D., Unnikrishnan, G., Kolanthai, E., & Senthilkumar, M. (2024) · Next Materials · doi:10.1016/j.nxmate.2024.100405 · Cited by 2
Fogang, L. T., Sølling, T. I., Pedersen, J. S., Kamal, M. S., & Sultan, A. S. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c00922 · Cited by 2
Vinod, N., Hwang, D., Fussell, S. C., Owens, T. C., Tofade, O. C., Benefield, T., Copling, S. A., Ramsey, J. D., Rädler, P. D., Atkins, H., et al. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10681 · Cited by 3
“22,32 Our goal in this study was to evaluate whether this platform technology could constitutively active and undergoes autophosphorylation.”
Self-citationRay, S., & Singh, D. (2024) · Current Drug Therapy · doi:10.2174/0115748855302263240910060240 · Cited by 3
Singh, R. P., Yadav, B., Chauhan, M., Shekhar, S., Nayak, A. K., Dutt, R., & Sonali (2022) · Current Protein and Peptide Science · doi:10.2174/1389203724666221102164756 · Cited by 1
Deng, Y., Tan, S., Zhao, X., Yu, J., & Tang, J. (2019) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201900032 · Cited by 1
Docking Design of the Different Microcapsules in Aqueous Solution and Its Quantitative On-Off Study
Tan, H.-F., Zhao, D., Liu, M., Hong, Z., Liu, J., Dai, K., & Xiao, X. (2023) · Polymers · doi:10.3390/polym15051131 · Cited by 1
“The multidrug delivery systems reported thus far allow the simultaneous loading of multiple drugs, and are generally based on the partitioning of a single carrier lumen and loading of different drugs into their corresponding closed compartments, such as layer-by-layer structures [11,12], double- or multi-chamber struc…”
BackgroundEtoposide-Loaded Colloidal Delivery Systems Based on Biodegradable Polymeric Carriers
Merkulova, M. A., Osipova, N., Kalistratova, A. V., Ermolenko, Y. V., & Gelperina, S. E. (2023) · Коллоидный журнал · doi:10.31857/s0023291223600463 · Cited by 1
Lübtow, M. M., Lorson, T., Finger, T., Gröber‐Becker, F., & Luxenhofer, R. (2019) · ChemRxiv · doi:10.26434/chemrxiv.8280761.v1 · Cited by 1
Developing of Micellar Drug Carriers for the Treatment of Breast Cancer Bone Metastasis
Liu, T. (2018) · DigitalCommons@UNMC
Trendbericht Makromolekulare Chemie
Gallei, M., Schmidt, B. V. K. J., & Barz, M. (2019) · Nachrichten aus der Chemie · doi:10.1002/nadc.20194089949
Lübtow, M. M., Lorson, T., Finger, T., Gröber‐Becker, F., & Luxenhofer, R. (2019) · ChemRxiv · doi:10.26434/chemrxiv.8280761
Zhu, Z., Peng, L., Luo, H., Jiang, Y., Yang, M., Gu, H., & Wang, Y. (2022) · medRxiv · doi:10.1101/2022.11.04.22281961
“NSCLC, which includes squamous cell lung carcinoma, large cell lung carcinoma, and lung adenocarcinoma (LUAD), accounts for roughly 85 percent of lung cancers[2, 6].”
BackgroundWang, Y. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1553
Nanotechnological tools for the diagnosis and treatment of cancer
Barbosa, F. G., Ribeaux, D. R., Raymundo, C. A. F. R., Martinez, D. L., Serrano-López, E. M., Copado, J. B., & Marcelino, P. R. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91763-6.00004-7
Peter, S., Naki, T., Alven, S., & Aderibigbe, B. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2119-5_25
Recent developments in pharmaceutical liquids
Basu, A., & Das, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91817-6.00019-x
Chen, B., Xia, Q., Li, J., Wang, C.-N., Zhang, L., & Wang, Q. (2025) · International Journal of Modern Physics C · doi:10.1142/s0129183125500810
Fussell, S. C. (2021) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/vsyg-vc90
UV emission quenching in silicon-coupled upconverting nanocomposites
Klimkevičius, V., Freiberg, K. E., Ežerskytė, E., & Sivakov, V. A. (2026) · Materials Research Bulletin · doi:10.1016/j.materresbull.2026.114062
Enzimatik Tepkimeler için Çok-Katmanlı Kapsüllerin Hazırlanması
Alemdar, C. (2024) · OpenMETU (Middle East Technical University)
Contribution to physico-chemical studies of squalenoylated nanomedicines for cancer treatment
Mougin, J. (2020) · theses.fr (ABES) · doi:10.70675/60919eb5z6381z458fzaf60zfef9dd960954
Nanotechnology in Cancer Therapy: Small Wonders, Big Magic
Arora, K., Sharma, U., Dubey, S., Sapra, R., & Jain, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814144126010010
Layered Zirconium Phosphate Nanocarriers for Mitoxantrone: Advancing Targeted Chemotherapy
López-Cubero, A., Sánchez, M. M., Cabrera-Rivera, G., Santiago, A., Rivera, Y., Jang, S., González, M. L., Martínez‐Ferrer, M., & Colón, J. L. (2026) · ACS Omega · doi:10.1021/acsomega.6c01791
Jana, S., & Hoogenboom, R. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115975
Colaco, V., Gupta, A., Jadhav, S. R., Rajora, A. D., Saha, M., Adile, S., Roy, A. A., Soman, S., Moorkoth, S., Datta, D., et al. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100701
Metadata
- Authors
- Wan, X., Min, Y., Bludau, H., Keith, A., Sheiko, S. S., Jordan, R., Wang, A. Z., Sokolsky-Papkov, M., & Kabanov, A. V.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Technische Universität Dresden (DE)
- Center for Nanotechnology in Drug Delivery and Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
- Corresponding author
- Kabanov, Alexander V.
- ORCID
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-03-13
- Volume
- 12
- Issue
- 3
- Pages
- 2426-2439
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- PMC
- PMC5960350
- OpenAlex
- W2792801574
- Cited by
- 158
- References
- 30
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 11 · 2023: 14 · 2022: 25 · 2021: 25 · 2020: 27 · 2019: 28 · 2018: 12
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Cancer Institute (U01 CA116591, U54 CA198999, R21 CA182322)
- China Scholarship Council (2011601254)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Surfactants and Colloidal Systems
- Keywords
- poly(2-oxazoline), small cell lung cancer, non-small cell lung cancer, etoposide, cisplatin prodrug, platinum drugs, drug synergy, amphiphilic block copolymers, controlled drug release, tumor distribution, pharmacokinetics, anticancer activity
- MeSH terms
- Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Cisplatin, Drug Carriers, Drug Synergism, Etoposide, Female, Humans, Lung Neoplasms, Mice, Nude, Micelles, Polymers, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.